top of page
ARTICLES
Explore published articles and webinars from Litmys leaders that spotlight new thinking and practical approaches to achieving market success across the life sciences.
Managing Partner, Harris Kaplan, joins industry experts in FirstWord ExpertViews: The Future Impact of the Inflation Reduction Act on Pharma Drug Pricing
The decisions that shape commercial success are increasingly being made long before launch. As the Inflation Reduction Act continues to influence pricing, access, and reimbursement dynamics, companies must consider how evidence generation, differentiation, and value communication fit into their development strategy from the outset. In FirstWord's ExpertViews report, The Future Impact of the Inflation Reduction Act on Pharma Drug Pricing, Harris Kaplan shares his perspective a
Jun 41 min read
Managing Partner, Harris Kaplan, published in BioSpace: Why KOL Enthusiasm Often Doesn’t Predict Commercial Success
KOL enthusiasm can signal early promise, but it rarely tells the full story. Harris Kaplan examines why expert advocacy often fails to translate into market adoption—and what life sciences teams should evaluate instead.
Apr 221 min read
Managing Partner, Harris Kaplan, published in In Vivo: Physician Behavioral Inertia - Innovation’s Greatest Enemy
Harris Kaplan , Managing Partner, just published an article in In Vivo, Physician Behavioral Inertia: Innovation’s Greatest Enemy ....
Sep 26, 20231 min read
Managing Partner, Harris Kaplan, published in PharmExec: Marketers - Physicians are People First
Harris Kaplan , Managing Partner, just published an article in PharmExec (titled Marketers: Physicians are People First ) that looks at...
Nov 17, 20201 min read
bottom of page